Zobrazeno 1 - 10
of 72
pro vyhledávání: '"A E Storozhakova"'
Autor:
O I Kit, L Y Vladimirova, N A Abramova, A E Storozhakova, I L Popova, N M Tikhanovskaya, A A Lyaynova, L A Ryadinskaya
Publikováno v:
Современная онкология, Vol 19, Iss 2, Pp 42-46 (2017)
The data of the efficacy and safety regorafenib in the treatment of 7 patients with metastatic colorectal cancer (mCRC) refractory to treatment with cytostatics and monoclonal antibodies - blockers EGFR and VEGF were analyzed. The maximum anti-tumor
Externí odkaz:
https://doaj.org/article/e022525b6858401aaef3c15fabbf6fb3
Publikováno v:
Современная онкология, Vol 18, Iss 3, Pp 65-68 (2016)
The main treatment for metastatic soft tissue sarcomas is chemotherapy (CT); neutropenia is its frequent complication that is treated with various colony stimulating factors (CSFs). The purpose of the study was to assess the treatment effectiveness a
Externí odkaz:
https://doaj.org/article/7d11e1cbfd8c432083ec70940c092186
Autor:
L V Bolotina, L V Manziuk, V A Gorbunova, E I Kovalenko, G Z Mukhametshina, A I Khasanova, L Yu Vladimirova, I S Mitashok, E P Prokofyeva, I V Evstigneeva, I I Andreyashkina, N A Abramova, I L Popova, E V Karabina, A A Teterich, E A Gaysina, V A Chubenko, S V Limareva, N M Tikhanovskaya, A E Storozhakova, N Yu Samaneva, Ya V Svetitskaya, T A Snezhko, E A Kalabanova
Publikováno v:
Современная онкология, Vol 18, Iss 3, Pp 27-32 (2016)
The article shows the experience of eribulin application in actual clinical practice in Oncology institutions of the Russian Federation concerning metastatic breast cancer. We have analyzed the efficacy of the drug in case of different subtypes of th
Externí odkaz:
https://doaj.org/article/02544f99d49748aabf8218f99df2b907
Autor:
A. A. Lyanova, L. Yu. Vladimirova, E. P. Ulyanova, N. A. Abramova, A. E. Storozhakova, I. L. Popova, N. M. Tikhanovskaya, M. A. Teplyakova, L. A. Ryadinskaya, I. A. Udalenkova, E. A. Kalabanova, S. N. Kabanov
Publikováno v:
Южно-Российский онкологический журнал, Vol 3, Iss 4, Pp 40-48 (2022)
Purpose of the study. An analysis of changes in the expression of the VEGF neoangiogenic factor in the tumor tissue of patients with squamous cell carcinoma of the oral mucosa receiving targeted therapy with cetuximab and chemotherapy.Patients and me
Externí odkaz:
https://doaj.org/article/aaad8131f37d45919c047248caac54d3
Autor:
L. Yu. Vladimirova, E. M. Frantsiyants, N. A. Abramova, K. A. Novoselova, V. S. Myagkova, O. V. Katelnitskaya, A. E. Storozhakova, I. L. Popova, S. N. Kabanov, N. M. Tikhanovskaya, E. A. Kalabanova, L. A. Ryadinskaya, A. A. Lyanova, M. A. Teplyakova, V. R. Zakharchenko, N. K. Guskova
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 9, Iss 3, Pp 25-38 (2022)
Purpose of the study. An analysis of parameters of the blood coagulation system in breast cancer patients after coronavirus disease.Materials and methods. 50 breast cancer patients were divided into groups: the main group included 30 patients after c
Externí odkaz:
https://doaj.org/article/11865fec689245e7beb91d9a5389d4d9
Autor:
E. M. Frantsiyants, N. Yu. Samaneva, L. Yu. Vladimirova, A. E. Storozhakova, E. A. Kalabanova, S. N. Kabanov, A. V. Tishina
Publikováno v:
Южно-Российский онкологический журнал, Vol 2, Iss 3, Pp 6-12 (2021)
Purpose of the study. An analysis of blood levels of TGF-β, TGFR2, TNF-α, TNF-αR1, TNF-αR2, CD44 and MMP9 in patients with various biological subtypes of breast cancer receiving neoadjuvant chemotherapy.Materials and methods. This article present
Externí odkaz:
https://doaj.org/article/2fe7227ba9174294bd9da635b4d2499d
Autor:
O. I. Kit, L. Yu. Vladimirova, E. A. Kalabanova, A. E. Storozhakova, S. N. Kabanov, T. A. Snezhko, I. S. Mitashok, Ya. V. Svetitskaya, N. Yu. Samaneva, I. S. Kornilova, Yu. V. Przhedetskiy, V. V. Pozdnyakova, N. A. Abramova, I. L. Popova, N. M. Tikhanovskaya, A. A. Lyanova, K. A. Novoselova, L. A. Ryadinskaya
Publikováno v:
Сибирский онкологический журнал, Vol 20, Iss 2, Pp 85-92 (2021)
Background. Breast cancer is one of the most common malignancies and one of the leading causes of cancer deaths among women in the Russian Federation. The prognosis of the disease is largely determined by thebiological subtype of the tumor. Her2-posi
Externí odkaz:
https://doaj.org/article/37520b7ab3864c81a9d042b834977f6f
Autor:
L. Yu. Vladimirova, A. E. Storozhakova, E. A. Kalabanova, P. N. Meshcheryakov, S. V. Oskin, S. N. Kabanov, N. Yu. Samaneva, Ya. V. Svetitskaya, A. V. Tishina
Publikováno v:
Южно-Российский онкологический журнал, Vol 2, Iss 1, Pp 35-42 (2021)
Lung cancer is among the most common malignant diseases in Russia. In 80–90%, its morphological type is nonsmall cell lung cancer. Stage IV primary advanced lung cancer is diagnosed in 41% of patients. Median overall survival in stage IV patients r
Externí odkaz:
https://doaj.org/article/076418e5fa3841ad91f9a0ffc47fbf9e
Autor:
L. Yu. Vladimirova, A. E. Storozhakova, E. A. Kalabanova, E. V. Verenikina, S. N. Kabanov, Ya. V. Svetitskaya, N. Yu. Samaneva, N. M. Tikhanovskaya, K. A. Novoselova, O. G. Selezneva, A. V. Tishina
Publikováno v:
Южно-Российский онкологический журнал, Vol 1, Iss 3, Pp 67-74 (2020)
Ovarian cancer is one of the most common cancers in women. Growth and extension of the tumor are associated with active neoangiogenesis regulated by vascular endothelial growth factor (VEGF). Bevacizumab decreases VEGF activity and inhibits the tumor
Externí odkaz:
https://doaj.org/article/763932498d0d422f939dd5d540dfdd16
Autor:
L. Yu. Vladimirova, A. E. Storozhakova, T. A. Snezhko, L. K. Strakhova, N. A. Abramova, S. N. Kabanov, E. A. Kalabanova, N. Yu. Samaneva, Ya. V. Svetitskaya, A. V. Tishina
Publikováno v:
Южно-Российский онкологический журнал, Vol 1, Iss 2, Pp 46-51 (2020)
Breast cancer (BC) is the most common female cancer and the first leading cause of cancer death in women. Luminal phenotypes represent about 70% of this disease. Treatment for metastatic hormone‑dependent HER2‑negative breast cancer in most cases
Externí odkaz:
https://doaj.org/article/cb0804c095b04460bf60ce7513a4a3dd